Ekser, B and Klein, E and He, J and Stolz, DB and Echeverri, GJ and Long, C and Lin, CC and Ezzelarab, M and Hara, H and Veroux, M and Ayares, D and Cooper, DKC and Gridelli, B
(2012)
Genetically-engineered pig-to-baboon liver xenotransplantation: Histopathology of xenografts and native organs.
PLoS ONE, 7 (1).
Abstract
Orthotopic liver transplantation was carried out in baboons using wild-type (WT, n = 1) or genetically-engineered pigs (α1,3-galactosyltransferase gene-knockout, GTKO), n = 1; GTKO pigs transgenic for human CD46, n = 7) and a clinically-acceptable immunosuppressive regimen. Biopsies were obtained from the WT pig liver pre-Tx and at 30 min, 1, 2, 3, 4 and 5 h post-transplantation. Biopsies of genetically-engineered livers were obtained pre-Tx, 2 h after reperfusion and at necropsy (4-7 days after transplantation). Tissues were examined by light, confocal, and electron microscopy. All major native organs were also examined. The WT pig liver underwent hyperacute rejection. After genetically-engineered pig liver transplantation, hyperacute rejection did not occur. Survival was limited to 4-7 days due to repeated spontaneous bleeding in the liver and native organs (as a result of profound thrombocytopenia) which necessitated euthanasia. At 2 h, graft histology was largely normal. At necropsy, genetically-engineered pig livers showed hemorrhagic necrosis, platelet aggregation, platelet-fibrin thrombi, monocyte/macrophage margination mainly in liver sinusoids, and vascular endothelial cell hypertrophy, confirmed by confocal and electron microscopy. Immunohistochemistry showed minimal deposition of IgM, and almost absence of IgG, C3, C4d, C5b-9, and of a cellular infiltrate, suggesting that neither antibody- nor cell-mediated rejection played a major role. © 2012 Ekser et al.
Share
Citation/Export: |
|
Social Networking: |
|
Details
Item Type: |
Article
|
Status: |
Published |
Creators/Authors: |
Creators | Email | Pitt Username | ORCID |
---|
Ekser, B | | | | Klein, E | eklein@pitt.edu | EKLEIN | | He, J | | | | Stolz, DB | donna.stolz@pitt.edu | DSTOLZ | | Echeverri, GJ | | | | Long, C | cal46@pitt.edu | CAL46 | | Lin, CC | | | | Ezzelarab, M | mbe8@pitt.edu | MBE8 | 0000-0002-3919-5250 | Hara, H | hih3@pitt.edu | HIH3 | | Veroux, M | | | | Ayares, D | | | | Cooper, DKC | cooperdk@pitt.edu | COOPERDK | | Gridelli, B | | | |
|
Contributors: |
Contribution | Contributors Name | Email | Pitt Username | ORCID |
---|
Editor | Zimmerman, Michael | UNSPECIFIED | UNSPECIFIED | UNSPECIFIED |
|
Centers: |
Other Centers, Institutes, Offices, or Units > Thomas E. Starzl Transplantation Institute |
Date: |
11 January 2012 |
Date Type: |
Publication |
Journal or Publication Title: |
PLoS ONE |
Volume: |
7 |
Number: |
1 |
DOI or Unique Handle: |
10.1371/journal.pone.0029720 |
Schools and Programs: |
School of Medicine > Cell Biology and Molecular Physiology |
Refereed: |
Yes |
MeSH Headings: |
Animals; Animals, Genetically Modified; Female; Galactosyltransferases--physiology; Genetic Engineering; Graft Rejection--immunology; Graft Rejection--pathology; Humans; Liver--immunology; Liver--pathology; Liver Failure--immunology; Liver Failure--therapy; Liver Transplantation--immunology; Liver Transplantation--pathology; Male; Papio; Sus scrofa; Transplantation, Heterologous--immunology; Transplantation, Heterologous--pathology |
Other ID: |
NLM PMC3256162 |
PubMed Central ID: |
PMC3256162 |
PubMed ID: |
22247784 |
Date Deposited: |
13 Sep 2012 15:24 |
Last Modified: |
15 Jan 2024 15:55 |
URI: |
http://d-scholarship.pitt.edu/id/eprint/14014 |
Metrics
Monthly Views for the past 3 years
Plum Analytics
Altmetric.com
Actions (login required)
|
View Item |